Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: Egebäck Arulf, Sofiaa | Ziyue Zhou, Robina | Kirsebom, Bjørn-Eivindb; c; d; e | Jejcic, Alenkaa | Fladby, Tormodd; e | Winblad, Bengta; f; * | Tjernberg, Larsa; * | Schedin-Weiss, Sophiaa; *
Affiliations: [a] Department of Neurobiology, Division of Neurogeriatrics, Care Sciences and Society, Center for Alzheimer Research, Karolinska Institutet, Solna, Sweden | [b] Department of Neurology, University Hospital of North Norway, Troms–, Norway | [c] Department of Psychology, Faculty of Health Sciences, The Arctic University of Norway, Troms–, Norway | [d] Department of Neurology, Akershus University Hospital, L–renskog, Norway | [e] Institute of Clinical Medicine, University of Oslo, Oslo, Norway | [f] Theme Inflammation and Aging, Karolinska University Hospital, Huddinge, Sweden
Correspondence: [*] Correspondence to: Bengt Winblad, Lars Tjernberg, and Sophia Schedin Weiss, Department of Neurobiology, Division of Neurogeriatrics, Care Sciences and Society, Center for Alzheimer Research, Karolinska Institutet, BioClinicum, J9:20, Visionsgatan 4, 171 64 Solna, Sweden. E-mails: bengt.winblad@ki.se; lars.tjernberg@ki.se; sophia.schedin.weiss@ki.se.
Abstract: Background:The N-glycan structure bisecting N-acetylglucosamine (bisecting GlcNAc) is present on several N-glycans that are elevated in Alzheimer’s disease (AD), and previous studies have shown that bisecting GlcNAc levels correlate with total tau and phospho-tau181 in cerebrospinal fluid at early stages of AD. A recent population-based study showed that bisecting GlcNAc correlates with total tau also in blood and that this correlation could predict conversion to dementia. Objective:In this study, we have further investigated how bisecting GlcNAc relates to total tau and phospho-tau 181 in cerebrospinal fluid samples from controls and cases with early cognitive deficits, stratified by amyloid/tau status and gender. Methods:Relative levels of bisecting GlcNAc in cerebrospinal fluid were measured by an enzyme-linked lectin assay in individuals with subjective cognitive decline, mild cognitive impairment and controls from the Norwegian Dementia Disease Initiation cohort. Results:As in our previous study, the correlation between bisecting GlcNAc and total tau or phospho-tau181 was particularly strong in the subjective cognitive decline group. The correlation was observed in amyloid negative and tau negative as well as amyloid positive and tau positive individuals, both in females and in males. Interestingly, among the amyloid negative and tau negative individuals, the correlation was observed in individuals with subjective cognitive decline but not in the controls. Conclusions:Thus, bisecting GlcNAc could be a biomarker for early cognitive decline.
Keywords: Alzheimer’s disease, bisecting N-acetylglucosamine, dementia, mild cognitive impairment, N-glycosylation, phospho-tau, subjective cognitive decline, total tau
DOI: 10.3233/JAD-240628
Journal: Journal of Alzheimer's Disease, vol. 100, no. s1, pp. S93-S101, 2024
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
sales@iospress.com
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
info@iospress.nl
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office info@iospress.nl
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
china@iospress.cn
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
如果您在出版方面需要帮助或有任何建, 件至: editorial@iospress.nl